levofloxacin has been researched along with cudc 101 in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (cudc 101) | Trials (cudc 101) | Recent Studies (post-2010) (cudc 101) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 39 | 2 | 35 |
| Protein | Taxonomy | levofloxacin (IC50) | cudc 101 (IC50) |
|---|---|---|---|
| Histone deacetylase 3 | Homo sapiens (human) | 0.1561 | |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 2.89 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.0046 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.0525 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 5.91 | |
| Tyrosine-protein kinase Lyn | Homo sapiens (human) | 0.84 | |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | 3.2 | |
| Fibroblast growth factor receptor 2 | Homo sapiens (human) | 3.43 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.849 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 1.5 | |
| Histone deacetylase 4 | Homo sapiens (human) | 0.1567 | |
| Fatty-acid amide hydrolase 1 | Rattus norvegicus (Norway rat) | 3.7086 | |
| Histone deacetylase 1 | Homo sapiens (human) | 0.1554 | |
| Histone deacetylase 7 | Homo sapiens (human) | 0.2081 | |
| Histone deacetylase 2 | Homo sapiens (human) | 0.1566 | |
| Polyamine deacetylase HDAC10 | Homo sapiens (human) | 0.1815 | |
| Histone deacetylase 11 | Homo sapiens (human) | 0.1806 | |
| Histone deacetylase 8 | Homo sapiens (human) | 0.1662 | |
| Histone deacetylase 6 | Homo sapiens (human) | 0.1555 | |
| Histone deacetylase 9 | Homo sapiens (human) | 0.1644 | |
| Histone deacetylase 5 | Homo sapiens (human) | 0.1564 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuo-Rahma, GEA; Badr, M; Bass, AKA; El-Zoghbi, MS; Mohamed, MFA; Nageeb, EM | 1 |
1 review(s) available for levofloxacin and cudc 101
| Article | Year |
|---|---|
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
Topics: Androgen Antagonists; Animals; Antineoplastic Agents; Benzimidazoles; Cyclic Nucleotide Phosphodiesterases, Type 5; Daunorubicin; Doxorubicin; fms-Like Tyrosine Kinase 3; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Molecular Targeted Therapy; Morpholines; Nicotinamide Phosphoribosyltransferase; Nitric Oxide; Pyrimidines; Quinazolines; Structure-Activity Relationship; Transcription Factors | 2021 |